Skip to main content
Top
Published in: Endocrine 1/2016

01-04-2016 | Original Article

Follow-up ultrasound may be enough for thyroid nodules from 5 mm to 1 cm in size

Authors: Soo-Yeon Kim, Hye Sun Lee, Eun-Kyung Kim, Hee Jung Moon, Jung Hyun Yoon, Jung Hwa Hong, Jin Young Kwak

Published in: Endocrine | Issue 1/2016

Login to get access

Abstract

We investigated whether follow-up ultrasound (US) is enough for thyroid nodules 5–10 mm, and whether 3 years of interval between the initial US and next US is appropriate. This retrospective study was approved by the Institutional Review Board, and the need to obtain informed consent was waived. The study included 447 thyroid nodules 5–10 mm from 378 patients who underwent initial thyroid US, and underwent 3 years or more of follow-up US. The presence and characteristics of malignancy detected on follow-up were reviewed. Maximal diameters of each nodule at the initial and last US were measured. Univariate and multivariate analysis were used to assess association with nodule growth 3 mm or larger. Seven malignancies (1.6 %, 7 of 447) were detected on a mean 70.6 ± 20.3 months (range 36–104 months). Only one had growth 3 mm or larger, and all malignancies did not have extensive extrathyroidal extension, lateral lymph nodes, or distant metastasis. 6.0 % (27 of 447) of nodules had growth 3 mm or larger. Nodules in older patients were less likely to grow, and benign-looking nodules were more likely to grow. Longer follow-up time 6 years or more was not associated with growth, and no cancers were detected during the long follow-up time. Immediate US-FNA for thyroid nodules 5–10 mm are discouraged, unless suspicious metastatic lymph nodes are present. Also, a follow-up US 3 years after the initial US may be enough for these nodules.
Literature
1.
go back to reference Bryan R. Haugen, Erik K. Alexander, Keith C. Bible, Gerard M. Doherty, S.J. Mandel, American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 167 (2014) Bryan R. Haugen, Erik K. Alexander, Keith C. Bible, Gerard M. Doherty, S.J. Mandel, American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 167 (2014)
2.
go back to reference G.H. Tan, H. Gharib, Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann. Intern. Med. 126(3), 226–231 (1997)CrossRefPubMed G.H. Tan, H. Gharib, Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann. Intern. Med. 126(3), 226–231 (1997)CrossRefPubMed
3.
go back to reference R. Tuttle, D. Ball, D. Byrd, P. Dickson, Q. Duh, W. Farrar, NCCN Clinical Practice Guidelines in Oncology-Thyroid Carcinoma-Version 2.2013. NCCN Guidelines (2013) R. Tuttle, D. Ball, D. Byrd, P. Dickson, Q. Duh, W. Farrar, NCCN Clinical Practice Guidelines in Oncology-Thyroid Carcinoma-Version 2.2013. NCCN Guidelines (2013)
4.
go back to reference M.C. Frates, C.B. Benson, J.W. Charboneau, E.S. Cibas, O.H. Clark, B.G. Coleman, J.J. Cronan, P.M. Doubilet, D.B. Evans, J.R. Goellner, Management of thyroid nodules detected at US: society of radiologists in ultrasound consensus conference statement 1. Radiology 237(3), 794–800 (2005)CrossRefPubMed M.C. Frates, C.B. Benson, J.W. Charboneau, E.S. Cibas, O.H. Clark, B.G. Coleman, J.J. Cronan, P.M. Doubilet, D.B. Evans, J.R. Goellner, Management of thyroid nodules detected at US: society of radiologists in ultrasound consensus conference statement 1. Radiology 237(3), 794–800 (2005)CrossRefPubMed
5.
go back to reference K. Pazaitou-Panayiotou, M. Capezzone, F. Pacini, Clinical features and therapeutic implication of papillary thyroid microcarcinoma. Thyroid 17(11), 1085–1092 (2007)CrossRefPubMed K. Pazaitou-Panayiotou, M. Capezzone, F. Pacini, Clinical features and therapeutic implication of papillary thyroid microcarcinoma. Thyroid 17(11), 1085–1092 (2007)CrossRefPubMed
6.
go back to reference Y. Ito, A. Miyauchi, H. Inoue, M. Fukushima, M. Kihara, T. Higashiyama, C. Tomoda, Y. Takamura, K. Kobayashi, A. Miya, An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J. Surg. 34(1), 28–35 (2010)CrossRefPubMed Y. Ito, A. Miyauchi, H. Inoue, M. Fukushima, M. Kihara, T. Higashiyama, C. Tomoda, Y. Takamura, K. Kobayashi, A. Miya, An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J. Surg. 34(1), 28–35 (2010)CrossRefPubMed
7.
go back to reference Y. Ito, A. Miyauchi, M. Kihara, T. Higashiyama, K. Kobayashi, A. Miya, Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24(1), 27–34 (2014)CrossRefPubMedPubMedCentral Y. Ito, A. Miyauchi, M. Kihara, T. Higashiyama, K. Kobayashi, A. Miya, Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24(1), 27–34 (2014)CrossRefPubMedPubMedCentral
8.
go back to reference Y. Ito, A. Miyauchi, K. Kobayashi, A. Miya, Prognosis and growth activity depend on patient age in clinical and subclinical papillary thyroid carcinoma. Endocr. J. 61(3), 205–213 (2014)CrossRefPubMed Y. Ito, A. Miyauchi, K. Kobayashi, A. Miya, Prognosis and growth activity depend on patient age in clinical and subclinical papillary thyroid carcinoma. Endocr. J. 61(3), 205–213 (2014)CrossRefPubMed
9.
go back to reference I. Sugitani, K. Toda, K. Yamada, N. Yamamoto, M. Ikenaga, Y. Fujimoto, Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J. Surg. 34(6), 1222–1231 (2010)CrossRefPubMed I. Sugitani, K. Toda, K. Yamada, N. Yamamoto, M. Ikenaga, Y. Fujimoto, Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J. Surg. 34(6), 1222–1231 (2010)CrossRefPubMed
10.
go back to reference W.-J. Moon, J.H. Baek, S.L. Jung, D.W. Kim, E.K. Kim, J.Y. Kim, J.Y. Kwak, J.H. Lee, J.H. Lee, Y.H. Lee, Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J. Radiol. 12(1), 1–14 (2011)CrossRefPubMedPubMedCentral W.-J. Moon, J.H. Baek, S.L. Jung, D.W. Kim, E.K. Kim, J.Y. Kim, J.Y. Kwak, J.H. Lee, J.H. Lee, Y.H. Lee, Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J. Radiol. 12(1), 1–14 (2011)CrossRefPubMedPubMedCentral
11.
go back to reference K.-E. Kim, E.-K. Kim, J.H. Yoon, K.H. Han, H.J. Moon, J.Y. Kwak, Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features. World J. Surg. 37(2), 385–391 (2013)CrossRefPubMed K.-E. Kim, E.-K. Kim, J.H. Yoon, K.H. Han, H.J. Moon, J.Y. Kwak, Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features. World J. Surg. 37(2), 385–391 (2013)CrossRefPubMed
12.
go back to reference J.Y. Kwak, E.-K. Kim, H.J. Kim, M.J. Kim, E.J. Son, H.J. Moon, How to combine ultrasound and cytological information in decision making about thyroid nodules. Eur. Radiol. 19(8), 1923–1931 (2009)CrossRefPubMed J.Y. Kwak, E.-K. Kim, H.J. Kim, M.J. Kim, E.J. Son, H.J. Moon, How to combine ultrasound and cytological information in decision making about thyroid nodules. Eur. Radiol. 19(8), 1923–1931 (2009)CrossRefPubMed
13.
go back to reference H.J. Moon, J.Y. Kwak, E.-K. Kim, M.J. Kim, C.S. Park, W.Y. Chung, E.J. Son, The combined role of ultrasound and frozen section in surgical management of thyroid nodules read as suspicious for papillary thyroid carcinoma on fine needle aspiration biopsy: a retrospective study. World J. Surg. 33(5), 950–957 (2009)CrossRefPubMed H.J. Moon, J.Y. Kwak, E.-K. Kim, M.J. Kim, C.S. Park, W.Y. Chung, E.J. Son, The combined role of ultrasound and frozen section in surgical management of thyroid nodules read as suspicious for papillary thyroid carcinoma on fine needle aspiration biopsy: a retrospective study. World J. Surg. 33(5), 950–957 (2009)CrossRefPubMed
14.
go back to reference E.-K. Kim, C.S. Park, W.Y. Chung, K.K. Oh, D.I. Kim, J.T. Lee, H.S. Yoo, New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am. J. Roentgenol. 178(3), 687–691 (2002)CrossRef E.-K. Kim, C.S. Park, W.Y. Chung, K.K. Oh, D.I. Kim, J.T. Lee, H.S. Yoo, New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am. J. Roentgenol. 178(3), 687–691 (2002)CrossRef
15.
go back to reference S.L. Zeger, K.Y. Liang, Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121–130 (1986)CrossRefPubMed S.L. Zeger, K.Y. Liang, Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121–130 (1986)CrossRefPubMed
16.
go back to reference L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18), 2164–2167 (2006)CrossRefPubMed L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18), 2164–2167 (2006)CrossRefPubMed
17.
go back to reference L.J. Esserman, I.M. Thompson, B. Reid, Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 310(8), 797–798 (2013)CrossRefPubMed L.J. Esserman, I.M. Thompson, B. Reid, Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 310(8), 797–798 (2013)CrossRefPubMed
18.
go back to reference H.S. Ahn, H.J. Kim, H.G. Welch, Korea’s thyroid-cancer “epidemic”–screening and overdiagnosis. N. Engl. J. Med. 371(19), 1765–1767 (2014)CrossRefPubMed H.S. Ahn, H.J. Kim, H.G. Welch, Korea’s thyroid-cancer “epidemic”–screening and overdiagnosis. N. Engl. J. Med. 371(19), 1765–1767 (2014)CrossRefPubMed
19.
go back to reference J.-D. Lin, Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer. Med. Oncol. 27(2), 510–518 (2010)CrossRefPubMed J.-D. Lin, Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer. Med. Oncol. 27(2), 510–518 (2010)CrossRefPubMed
20.
21.
go back to reference S.-Y. Kim, K.H. Han, H.J. Moon, J.Y. Kwak, W.Y. Chung, E.K. Kim, Thyroid nodules with benign findings at cytologic examination: results of long-term follow-up with US. Radiology 271(1), 272–281 (2014)CrossRefPubMed S.-Y. Kim, K.H. Han, H.J. Moon, J.Y. Kwak, W.Y. Chung, E.K. Kim, Thyroid nodules with benign findings at cytologic examination: results of long-term follow-up with US. Radiology 271(1), 272–281 (2014)CrossRefPubMed
22.
go back to reference P. Rausch, K. Nowels, R.B. Jeffrey, Ultrasonographically guided thyroid biopsy: a review with emphasis on technique. J. Ultrasound Med. 20(1), 79–85 (2001)PubMed P. Rausch, K. Nowels, R.B. Jeffrey, Ultrasonographically guided thyroid biopsy: a review with emphasis on technique. J. Ultrasound Med. 20(1), 79–85 (2001)PubMed
23.
go back to reference C. Durante, G. Costante, G. Lucisano, R. Bruno, D. Meringolo, A. Paciaroni, E. Puxeddu, M. Torlontano, S. Tumino, M. Attard, The natural history of benign thyroid nodules. JAMA 313(9), 926–935 (2015)CrossRefPubMed C. Durante, G. Costante, G. Lucisano, R. Bruno, D. Meringolo, A. Paciaroni, E. Puxeddu, M. Torlontano, S. Tumino, M. Attard, The natural history of benign thyroid nodules. JAMA 313(9), 926–935 (2015)CrossRefPubMed
24.
go back to reference S. Ajmal, S. Rapoport, H.R. Batlle, P.J. Mazzaglia, The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy? J. Am. Coll. Surg. 220(6), 987–992 (2015)CrossRefPubMed S. Ajmal, S. Rapoport, H.R. Batlle, P.J. Mazzaglia, The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy? J. Am. Coll. Surg. 220(6), 987–992 (2015)CrossRefPubMed
25.
go back to reference T. Nishida, S.-I. Katayama, M. Tsujimoto, J.-I. Nakamura, H. Matsuda, Clinicopathological significance of poorly differentiated thyroid carcinoma. Am. J. Surg. Pathol. 23(2), 205–211 (1999)CrossRefPubMed T. Nishida, S.-I. Katayama, M. Tsujimoto, J.-I. Nakamura, H. Matsuda, Clinicopathological significance of poorly differentiated thyroid carcinoma. Am. J. Surg. Pathol. 23(2), 205–211 (1999)CrossRefPubMed
26.
go back to reference C. Are, A.R. Shaha, Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann. Surg. Oncol. 13(4), 453–464 (2006)CrossRefPubMed C. Are, A.R. Shaha, Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann. Surg. Oncol. 13(4), 453–464 (2006)CrossRefPubMed
27.
go back to reference M.F. Erdogan, A. Gursoy, G. Erdogan, Natural course of benign thyroid nodules in a moderately iodine-deficient area. Clin. Endocrinol. 65(6), 767–771 (2006)CrossRef M.F. Erdogan, A. Gursoy, G. Erdogan, Natural course of benign thyroid nodules in a moderately iodine-deficient area. Clin. Endocrinol. 65(6), 767–771 (2006)CrossRef
28.
go back to reference E.K. Alexander, S. Hurwitz, J.P. Heering, C.B. Benson, M.C. Frates, P.M. Doubilet, E.S. Cibas, P.R. Larsen, E. Marqusee, Natural history of benign solid and cystic thyroid nodules. Ann. Intern. Med. 138(4), 315–318 (2003)CrossRefPubMed E.K. Alexander, S. Hurwitz, J.P. Heering, C.B. Benson, M.C. Frates, P.M. Doubilet, E.S. Cibas, P.R. Larsen, E. Marqusee, Natural history of benign solid and cystic thyroid nodules. Ann. Intern. Med. 138(4), 315–318 (2003)CrossRefPubMed
29.
go back to reference B. Quadbeck, J. Pruellage, U. Roggenbuck, H. Hirche, O. Janssen, K. Mann, R. Hoermann, Long-term follow-up of thyroid nodule growth. Exp. Clin. Endocrinol. Diabetes 110(7), 348–354 (2002)CrossRefPubMed B. Quadbeck, J. Pruellage, U. Roggenbuck, H. Hirche, O. Janssen, K. Mann, R. Hoermann, Long-term follow-up of thyroid nodule growth. Exp. Clin. Endocrinol. Diabetes 110(7), 348–354 (2002)CrossRefPubMed
Metadata
Title
Follow-up ultrasound may be enough for thyroid nodules from 5 mm to 1 cm in size
Authors
Soo-Yeon Kim
Hye Sun Lee
Eun-Kyung Kim
Hee Jung Moon
Jung Hyun Yoon
Jung Hwa Hong
Jin Young Kwak
Publication date
01-04-2016
Publisher
Springer US
Published in
Endocrine / Issue 1/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0740-5

Other articles of this Issue 1/2016

Endocrine 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine